Venture Capital & Emerging Companies

We advise founders, emerging companies and investors across the entire venture capital lifecycle – from formation and first funding to international growth and exit. We combine deep venture capital expertise with best practice from one of Denmark’s leading M&A practices and specialist advice across all relevant legal disciplines. Through our dedicated investment funds team, we also advise on the establishment and structuring of venture capital funds.

We understand that emerging companies have different legal needs at different stages of their journey. Our approach is therefore flexible and commercial. We tailor our advice and offer legal packages designed around each company’s stage of development, ensuring that founders and management teams get the right level of support and access to the right specialists as the business evolves.

Our venture capital team advises on all types of venture and growth financings, from pre-seed and seed investments to Series A, B and later-stage rounds. We advise on investment and shareholders’ agreements, equity structure, convertible instruments, governance arrangements and incentive programmes. Acting for both companies and investors gives us valuable insight into the priorities, expectations and dynamics on both sides of the table.

For sponsors, our advice extends beyond individual investments. Plesner’s dedicated investment funds team advise venture capital managers on the establishment and structuring of VC funds which allows us to support VCs throughout the investment lifecycle – from fund formation and fundraising to investments, portfolio development and exits.

A key strength of our practice is the combination of specialist venture capital expertise and the transaction capabilities and best practice of Plesner’s leading M&A practice. As companies grow, our full-service platform provides seamless access to specialists across areas such as tax, employment and incentives, IP, data protection, regulatory matters, commercial contracts and capital markets. This enables us to remain a trusted legal partner as legal needs become more complex and the business expands internationally.

We have particular experience with emerging companies within regulatory tech and biopharma, where rapid growth, intellectual property, regulation and international expansion often create complex legal challenges.

Our ambition is to support ambitious companies, founders and investors throughout their journey – with pragmatic, commercially focused advice and the right specialist expertise at every stage.